Abstract
<b>Background:</b> Exercise capacity in idiopathic pulmonary fibrosis (IPF) is limited due to exercise-induced hypoxemia. This study is aimed to examine the effect of high-flow nasal cannula oxygen therapy (HFNC) on exercise tolerance in patients with IPF. <b>Methods:</b> This single-center, open-blind, randomized crossover trial assessed the influence of HFNC compared to venturi mask (VM) as the control test. Patients underwent constant load symptom-limited exercise tests at 80% of peak work rate with HFNC and VM in random order. The setting for HFNC was 60L/min, a FiO<sub>2</sub> of 50%, and VM was 12L/min, a FiO<sub>2</sub> of 50%. We measured endurance time as the primary outcome and heart rate, SpO2, dyspnea, and leg fatigue from modified borg scale at isotime and endpoint, comfort by using devices as the secondary outcomes. <b>Results:</b> 24 subjects (75.0% male; median [IQR] aged 77.5 years [68.8, 83.0]) were included. Compared to VM, HFNC significantly improved in endurance time (647.5sec [454.0, 1014.8] vs 577.5sec [338.0, 861.5), minimum SpO<sub>2</sub> (96.0% [95.0, 98.0] vs 94.0% [92.8, 96.0]) and leg fatigue from modified borg scale at isotime (3.0 [1.6, 4.0] vs 5.0 [3.0, 6.3]) and endpoint (4.0 [2.8, 5.0] vs 5.0 [3.8, 6.3]). There were no significant differences in maximum HR, dyspnea at isotime and endpoint, and comfort. <b>Conclusion:</b> HFNC increased exercise tolerance in stable IPF with exercise-induced hypoxemia.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.